Vitamin K2 Prevents Lymphoma in Drosophila

Maytham A. Dragh; Zhiliang Xu; Zainab S. Al-Allak; Ling Hong

doi:10.1038/s41598-017-17270-9

Scientific Reports (Dec 2017)

Vitamin K2 Prevents Lymphoma in Drosophila

Maytham A. Dragh,
Zhiliang Xu,
Zainab S. Al-Allak,
Ling Hong

Affiliations

Maytham A. Dragh: Department of Genetics and Developmental Biology, College of Life Science and Technology, Huazhong University of Science and Technology
Zhiliang Xu: Department of Genetics and Developmental Biology, College of Life Science and Technology, Huazhong University of Science and Technology
Zainab S. Al-Allak: Department of Biology College of Life Science, Misan University
Ling Hong: Department of Genetics and Developmental Biology, College of Life Science and Technology, Huazhong University of Science and Technology

DOI: https://doi.org/10.1038/s41598-017-17270-9
Journal volume & issue: Vol. 7, no. 1
pp. 1 – 15

Abstract

Read online

Abstract Previous studies have established the anticancer effect of vitamin K2 (VK2). However, its effect on lymphoma induced by UBIAD1/heix mutation in Drosophila remains unknown. Therefore, we aimed to develop an in vivo model of lymphoma for the precise characterization of lymphoma phenotypes. We also aimed to improve the understanding of the mechanisms that underlie the preventative effects of VK2 on lymphoma. Our results demonstrated that VK2 prevents lymphoma by acting as an electron carrier and by correcting the function and structure of mitochondria by inhibiting mitochondrial reactive oxygen species production mtROS. Our work identifies mitochondria as a key player in cancer therapy strategies.

Published in Scientific Reports

ISSN: 2045-2322 (Online)
Publisher: Nature Portfolio
Country of publisher: United Kingdom
LCC subjects: Medicine; Science
Website: https://www.nature.com/srep/

About the journal